| Literature DB >> 32223604 |
Swapna Karkare1, Hoa H Le1, John J Sheehan1, Jennifer Kern Sliwa1, Qiaoyi Zhang2, Beth Barber1.
Abstract
DISCLOSURES: The writing of this letter was supported by Janssen Scientific Affairs. The authors are employees of Janssen Scientific Affairs or Janssen Global Services (Johnson & Johnson).Entities:
Mesh:
Substances:
Year: 2020 PMID: 32223604 DOI: 10.18553/jmcp.2020.26.4.568
Source DB: PubMed Journal: J Manag Care Spec Pharm